Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 24 peer-reviewed journal articles Updated
Cardiology · Arrhythmogenic Cardiomyopathy

The Diagnostic Process: Putting the Puzzle Together

At a Glance

Arrhythmogenic Cardiomyopathy (ACM) is diagnosed using a points-based system called the 2020 Padua Criteria. A Cardiac MRI with gadolinium contrast is the most important test, as it can reveal the scar tissue and fat that replace healthy heart muscle in patients with ACM.

Diagnosing Arrhythmogenic Cardiomyopathy (ACM) is often described as putting together a complex puzzle. Because no single test can 100% prove or disprove the condition, doctors use a “points-based” system that combines imaging, electrical tests, and genetics [1][2].

The Modern Standard: The 2020 Padua Criteria

For years, doctors used the 2010 Task Force Criteria. However, those rules focused almost entirely on the right side of the heart (ARVC) [3][4].

In 2020, experts introduced the Padua Criteria. This updated framework is essential because it:

  • Recognizes Left-Sided Disease: It allows doctors to diagnose ACM even if the right side of the heart looks normal but the left side shows scarring [4][5].
  • Prioritizes Advanced Imaging: It places a high value on findings from Cardiac MRI (CMR), which can see things that an ultrasound (echocardiogram) might miss [4][6].

The “Gold Standard” Test: Cardiac MRI (CMR)

The most important tool in the ACM diagnostic toolkit is the Cardiac MRI [7][8]. During this test, you may receive an injection of a contrast agent called gadolinium.

The MRI looks for Late Gadolinium Enhancement (LGE) [4][9].

  • What it means: Healthy heart muscle washes the gadolinium away quickly. Scar tissue (fibrosis) or fat traps the gadolinium, causing it to “light up” on the scan later [9][10].
  • Why it matters: Seeing these “bright” spots allows doctors to visualize the exact areas where heart muscle has been replaced by fibrofatty tissue, which is the hallmark of ACM [11][10].

Why It’s Sometimes Confusing: The “Mimics”

ACM can look very similar to other heart conditions. Your doctor must carefully rule these out:

  • Athlete’s Heart: Long-term endurance training can naturally cause the heart to enlarge. Doctors use specialized strain analysis on an MRI to tell the difference between healthy “stretching” in an athlete and the pathological “weakening” of ACM [12][13].
  • Myocarditis: This is inflammation usually caused by a virus. While myocarditis is temporary, ACM is a lifelong genetic condition [14][15]. Genetic testing and checking for “recurrent” episodes are key to telling them apart [16][17].
  • Cardiac Sarcoidosis: This is an inflammatory disease that can also cause heart scarring. Doctors may use a PET scan to look for specific inflammation patterns that are common in sarcoidosis but rare in ACM [18][19].

Your Completeness Checklist

A “complete” workup for ACM should include several different types of information. If you are missing one of these, you may want to ask your doctor if it is needed:

  1. Electrical Tests: An ECG (resting) and a Holter Monitor (usually 24–72 hours) to count irregular heartbeats like PVCs (Premature Ventricular Contractions) [20][2].
  2. Structural Imaging: A Cardiac MRI with contrast (gadolinium) to look for scarring and wall motion issues [20][8].
  3. Genetic Testing: A blood or saliva test to look for mutations in genes like PKP2, DSP, or FLNC [21][22].
  4. Family History: A detailed review of any relatives who had heart failure or sudden cardiac events [23][14].
  5. Exercise Stress Test: To see how your heart rhythm responds when your heart rate increases [24].

Common questions in this guide

What is the 2020 Padua Criteria for diagnosing ACM?
The 2020 Padua Criteria is the modern framework doctors use to diagnose Arrhythmogenic Cardiomyopathy. Unlike older criteria, it helps doctors identify scarring on the left side of the heart and relies heavily on advanced imaging like Cardiac MRI.
Why is a Cardiac MRI considered the gold standard test for ACM?
A Cardiac MRI uses a contrast dye called gadolinium to highlight abnormal areas of the heart. It allows doctors to see exactly where healthy heart muscle has been replaced by scar tissue or fat, which is the key feature of ACM.
What does Late Gadolinium Enhancement (LGE) mean on my MRI report?
Late Gadolinium Enhancement means that the contrast dye from the MRI was trapped in certain areas of your heart. This "lighting up" on the scan indicates the presence of scar tissue or fibrosis rather than healthy heart muscle.
How do doctors tell the difference between ACM and an athlete's heart?
Long-term endurance sports can naturally cause the heart to enlarge, looking similar to ACM. Doctors use specialized strain analysis during a Cardiac MRI to distinguish between healthy athletic heart stretching and the abnormal changes caused by ACM.
What tests are needed for a complete ACM diagnostic workup?
A comprehensive evaluation usually includes electrical tests like an ECG and Holter monitor, a Cardiac MRI, genetic testing, a detailed family history review, and an exercise stress test.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Does my diagnosis follow the 2020 Padua Criteria or the 2010 Task Force Criteria?
  2. 2.What did the Late Gadolinium Enhancement (LGE) on my MRI show regarding scarring in both my right and left ventricles?
  3. 3.How did you rule out other conditions like cardiac sarcoidosis or chronic myocarditis in my case?
  4. 4.If my MRI was inconclusive, should I have a more specialized test like a PET scan or a repeat MRI in 6-12 months?
  5. 5.Does my specific genetic mutation (if found) change how we monitor or treat my condition?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (24)
  1. 1

    Arrhythmogenic right ventricular cardiomyopathy, clinical manifestations, and diagnosis.

    Haugaa KH, Haland TF, Leren IS, et al.

    Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2016; (18(7)):965-72 doi:10.1093/europace/euv340.

    PMID: 26498164
  2. 2

    A right ventricular bulge: A clinical dilemma in diagnosis.

    Allwood RP

    Journal of clinical ultrasound : JCU 2025; (53(1)):213-217 doi:10.1002/jcu.23848.

    PMID: 39301764
  3. 3

    New Diagnostic Approach to Arrhythmogenic Cardiomyopathy: The Padua Criteria.

    Graziano F, Zorzi A, Cipriani A, et al.

    Reviews in cardiovascular medicine 2022; (23(10)):335 doi:10.31083/j.rcm2310335.

    PMID: 39077127
  4. 4

    Evolving Diagnostic Criteria for Arrhythmogenic Cardiomyopathy.

    Corrado D, Zorzi A, Cipriani A, et al.

    Journal of the American Heart Association 2021; (10(18)):e021987 doi:10.1161/JAHA.121.021987.

    PMID: 34533054
  5. 5

    Myocarditis or inherited disease? - The multifaceted presentation of arrhythmogenic cardiomyopathy.

    Westphal DS, Krafft H, Biller R, et al.

    Gene 2022; (827()):146470 doi:10.1016/j.gene.2022.146470.

    PMID: 35381313
  6. 6

    The 2023 European Task Force Criteria for Diagnosis of Arrhythmogenic Cardiomyopathy: Historical Background and Review of Main Changes.

    Graziano F, Zorzi A, Ungaro S, et al.

    Reviews in cardiovascular medicine 2024; (25(9)):348 doi:10.31083/j.rcm2509348.

    PMID: 39355594
  7. 7

    Arrhythmogenic ventricular cardiomyopathy and sudden cardiac death: Left or right?

    Rachoin R, Saleh BA, Mansour B, et al.

    Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology 2017; (24(2)):527-533 doi:10.1007/s12350-016-0465-8.

    PMID: 26993493
  8. 8

    Value of cardiac magnetic resonance feature-tracking in Arrhythmogenic Cardiomyopathy (ACM): A systematic review and meta-analysis.

    MozafaryBazargany M, Salmanipour A, Ghaffari Jolfayi A, et al.

    International journal of cardiology. Heart & vasculature 2024; (53()):101455 doi:10.1016/j.ijcha.2024.101455.

    PMID: 39228971
  9. 9

    Arrhythmogenic right ventricular cardiomyopathy. Contribution of cardiac magnetic resonance imaging to the diagnosis.

    Perazzolo Marra M, Rizzo S, Bauce B, et al.

    Herz 2015; (40(4)):600-6 doi:10.1007/s00059-015-4228-0.

    PMID: 26077775
  10. 10

    Right ventricular arrhythmogenic cardiomyopathy: genetic and MR for modern clinical diagnosis.

    Graziosi M, Rapezzi C

    Journal of cardiovascular medicine (Hagerstown, Md.) 2017; (18 Suppl 1()):e157-e160 doi:10.2459/JCM.0000000000000470.

    PMID: 27828830
  11. 11

    Scarring/arrhythmogenic cardiomyopathy.

    Corrado D, Zorzi A, Cipriani A, et al.

    European heart journal supplements : journal of the European Society of Cardiology 2023; (25(Suppl C)):C144-C154 doi:10.1093/eurheartjsupp/suad017.

    PMID: 37125320
  12. 12

    Cardiac magnetic resonance based deformation imaging: role of feature tracking in athletes with suspected arrhythmogenic right ventricular cardiomyopathy.

    Czimbalmos C, Csecs I, Dohy Z, et al.

    The international journal of cardiovascular imaging 2019; (35(3)):529-538 doi:10.1007/s10554-018-1478-y.

    PMID: 30382474
  13. 13

    Arrhythmogenic Cardiomyopathy or "Athlete's Heart"?: A Systematic Approach to Differential Diagnosis.

    Minopoli TC, Kanthagnani K, Olivotto I, et al.

    JACC. Clinical electrophysiology 2025; (11(11)):2532-2547 doi:10.1016/j.jacep.2025.08.026.

    PMID: 41105061
  14. 14

    Arrhythmogenic Right Ventricular Cardiomyopathy Presenting as Clinical Myocarditis in Women.

    Scheel PJ, Murray B, Tichnell C, et al.

    The American journal of cardiology 2021; (145()):128-134 doi:10.1016/j.amjcard.2020.12.090.

    PMID: 33460606
  15. 15

    Monozygotic twins with myocarditis and a novel likely pathogenic desmoplakin gene variant.

    Kissopoulou A, Fernlund E, Holmgren C, et al.

    ESC heart failure 2020; (7(3)):1210-1216 doi:10.1002/ehf2.12658.

    PMID: 32301586
  16. 16

    Myocarditis-like Episodes in Patients with Arrhythmogenic Cardiomyopathy: A Systematic Review on the So-Called Hot-Phase of the Disease.

    Bariani R, Rigato I, Cipriani A, et al.

    Biomolecules 2022; (12(9)) doi:10.3390/biom12091324.

    PMID: 36139162
  17. 17

    Hot Phases Cardiomyopathy: Pathophysiology, Diagnostic Challenges, and Emerging Therapies.

    Bassetto G, Angriman F, Gava CPLD, et al.

    Current cardiology reports 2025; (27(1)):11.

    PMID: 39786662
  18. 18

    Biventricular Arrhythmogenic Cardiomyopathy Mimicking Cardiac Sarcoidosis.

    Kodali M, Galazka P, Ghafoor A, et al.

    JACC. Case reports 2024; (29(4)):102198 doi:10.1016/j.jaccas.2023.102198.

    PMID: 38379651
  19. 19

    Arrhythmic risk stratification in arrhythmogenic cardiomyopathy: new predictors for left-sided variants?

    Corrado D, Migliore F, Zorzi A

    European heart journal 2021; (42(29)):2851-2853 doi:10.1093/eurheartj/ehab355.

    PMID: 34151346
  20. 20

    Current Concepts on Diagnosis and Prognosis of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia.

    Castaños Gutiérrez SL, Kamel IR, Zimmerman SL

    Journal of thoracic imaging 2016; (31(6)):324-335 doi:10.1097/RTI.0000000000000171.

    PMID: 26429589
  21. 21

    A Systematic Analysis of the Clinical Outcome Associated with Multiple Reclassified Desmosomal Gene Variants in Arrhythmogenic Right Ventricular Cardiomyopathy Patients.

    Nagyova E, Hoorntje ET, Te Rijdt WP, et al.

    Journal of cardiovascular translational research 2023; (16(6)):1276-1286 doi:10.1007/s12265-023-10403-8.

    PMID: 37418234
  22. 22

    Diagnosis of Arrhythmogenic Cardiomyopathy in a Young Patient With Recurrent Myocarditis: The Importance of Genetic Testing.

    Morales JP, Spaccavento A, Guerchicoff M, et al.

    The American journal of cardiology 2025; (242()):37-40 doi:10.1016/j.amjcard.2025.01.034.

    PMID: 39929360
  23. 23

    High penetrance and similar disease progression in probands and in family members with arrhythmogenic cardiomyopathy.

    Chivulescu M, Lie ØH, Popescu BA, et al.

    European heart journal 2020; (41(14)):1401-1410 doi:10.1093/eurheartj/ehz570.

    PMID: 31504415
  24. 24

    Sudden death related cardiomyopathies - Arrhythmogenic right ventricular cardiomyopathy, arrhythmogenic cardiomyopathy, and exercise-induced cardiomyopathy.

    Goff ZD, Calkins H

    Progress in cardiovascular diseases 2019; (62(3)):217-226 doi:10.1016/j.pcad.2019.04.002.

    PMID: 31004608

This page provides educational information about the diagnostic process for arrhythmogenic cardiomyopathy (ACM). It is not a substitute for professional medical advice, diagnosis, or treatment from a qualified cardiologist or electrophysiologist.

Get notified when new evidence is published on Inherited arrhythmogenic cardiomyopathy.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.